- Mutation and haplotype analysis of phenylalanine hydroxylase alleles in classical PKU patients from the Czech Republic: identification of four novel mutations.1997 | Faculty of Physical Education and Sport
- Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients < 4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial2017 | Central Library of Charles University
- Hyperphenylalaninemia in the Czech Republic: Genotype-phenotype correlations and in silico analysis of novel missense mutations2013 | Third Faculty of Medicine
- Osteopenia - a potential complication of phenylketonuria2011 | Faculty of Medicine in Hradec Králové
- Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate2015 | First Faculty of Medicine
- Long-term efficacy and safety of sapropterin in patients who initiated sapropterin at < 4 years of age with phenylketonuria: results of the 3-year extension of the SPARK open-label, multicentre, randomised phase IIIb trial2021 | Third Faculty of Medicine